Under Trump, a New Focus for a Birth Control Program: Helping Women Get Pregnant

Sarepta defies FDA's request to halt Elevidys shipments, while GSK faces setbacks as an FDA panel rejects its blood cancer drug Blenrep, casting doubt on its comeback and causing stock decline.
All major sources, one page
Feel the mood behind headlines
Know what’s trending, globally
Get summaries. Save time
7,345
105
204
4 hours ago
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more
All major sources, one page
Feel the mood behind headlines
Know what’s trending, globally
Get summaries. Save time
7,345
105
204
4 hours ago
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more